Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 May 26;11(6):817.
doi: 10.3390/biology11060817.

Mechanisms of Cannabidiol (CBD) in Cancer Treatment: A Review

Camren G Heider  1 , Sasha A Itenberg  1 , Jiajia Rao  2 , Hang Ma  3 , Xian Wu  1
Affiliations
Review

Mechanisms of Cannabidiol (CBD) in Cancer Treatment: A Review

Camren G Heider et al. Biology (Basel). .

Abstract

Cannabis sativa L. (Cannabis) and its bioactive compounds, including cannabinoids and non-cannabinoids, have been extensively studied for their biological effects in recent decades. Cannabidiol (CBD), a major non-intoxicating cannabinoid in Cannabis, has emerged as a promising intervention for cancer research. The purpose of this review is to provide insights into the relationship between CBD and cancer based on recent research findings. The anticancer effects of CBD are mainly mediated via its interaction with the endocannabinoid system, resulting in the alleviation of pain and the promotion of immune regulation. Published reviews have focused on the applications of CBD in cancer pain management and the possible toxicological effects of its excessive consumption. In this review, we aim to summarize the mechanisms of action underlying the anticancer activities of CBD against several common cancers. Studies on the efficacy and mechanisms of CBD on cancer prevention and intervention in experimental models (i.e., cell culture- and animal-based assays) and human clinical studies are included in this review.

Keywords: Cannabis; apoptosis; cancer; cannabidiol (CBD); cannabinoid.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Major anticancer mechanisms of CBD on lung, breast, prostate, and colorectal cancers.
See this image and copyright information in PMC

References

    1. Zuk-Golaszewska K., Golaszewski J. Cannabis sativa L.—Cultivation and quality of raw material. J. Elem. 2018;23:971–984. doi: 10.5601/jelem.2017.22.3.1500. - DOI
    1. Rehman M.S.U., Rashid N., Saif A., Mahmood T., Han J.-I. Potential of bioenergy production from industrial hemp (Cannabis sativa): Pakistan perspective. Renew. Sustain. Energy Rev. 2013;18:154–164. doi: 10.1016/j.rser.2012.10.019. - DOI
    1. Śledziński P., Zeyland J., Słomski R., Nowak A. The current state and future perspectives of cannabinoids in cancer biology. Cancer Med. 2018;7:765–775. doi: 10.1002/cam4.1312. - DOI - PMC - PubMed
    1. Grotenhermen F., Müller-Vahl K. Medicinal Uses of Marijuana and Cannabinoids. Crit. Rev. Plant Sci. 2016;35:378–405. doi: 10.1080/07352689.2016.1265360. - DOI
    1. Pertwee R. The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Δ9-tetrahydrocannabinol, cannabidiol and Δ9-tetrahydrocannabivarin. Br. J. Pharmacol. 2008;153:199–215. doi: 10.1038/sj.bjp.0707442. - DOI - PMC - PubMed

LinkOut - more resources